AbbVie Execs Trim Holdings Amid Quiet Portfolio Rebalancing, Market Sees No Immediate Impact
AbbVie’s Chief HR Officer sells 1,594 shares, a small trim amid broader C‑suite sales; investors see a routine portfolio move, not a warning.
3 minutes to read

